文献速递乳房整形与再造

国家禁止杆菌肽冲洗后基于植入物的乳房再造结局

Outcomes After Implant-Based Breast Reconstruction Following the National Institution of a Ban on Bacitracin Irrigation.
PubMed 文献 · Ann Plast Surg · 2024-01-06

本研究为单机构回顾性病历审查,纳入2016年10月1日至2022年7月31日接受乳房切除术后植入物乳房再造的188例女性患者,分析美国食品药品监督管理局2020年1月31日禁止术中杆菌肽冲洗前后感染率。单变量和多变量分析均显示杆菌肽使用与术后感染无关,年龄大于50岁与术后感染风险增加相关(P=0.0366)。作者认为杆菌肽不被鼓励使用,需进一步研究围手术期冲洗的最佳抗生素。

要点

  • 单变量和多变量分析均显示杆菌肽冲洗与术后感染无关。
  • 年龄大于50岁与术后感染风险增加相关(P=0.0366)。
  • 合并症、吸烟状态、新辅助治疗、植入物放置和侧别与感染无显著关联。

核心结论

  • 本研究结果表明杆菌肽使用与术后感染之间缺乏关联。
  • 作者认为杆菌肽不被鼓励使用,需要进一步研究围手术期冲洗的最佳抗生素。

研究设计与样本

  • 单机构回顾性病历审查,纳入2016年10月1日至2022年7月31日接受乳房切除术后植入物乳房再造的188例女性患者。
  • 收集手术日期、再造类型、患者合并症、杆菌肽冲洗使用、术后感染和次要结局,进行单变量和多变量逻辑回归分析。

主要发现

  • 单变量和多变量分析中杆菌肽使用均未预防感染。
  • 年龄大于50岁与术后感染风险增加相关(P=0.0366)。
  • 合并症存在、吸烟状态、术前新辅助治疗、植入物放置和侧别均与术后感染发生无显著关联。

关键数值与推荐

  • 2020年1月31日美国食品药品监督管理局禁止含杆菌肽冲洗用于手术。
  • 年龄大于50岁与术后感染风险增加相关(P=0.0366)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of irrigation with bacitracin-containing solution is common among surgeons, as it was widely thought to have antibacterial properties and prevent postoperative infection. Current literature, however, suggests that antibiotic-containing irrigation confers little added benefit. On January 31, 2020, the Food and Drug Administration instituted a ban on bacitracin-containing irrigation for operative use. This study aimed to determine whether bacitracin has a beneficial effect on postoperative infection rates by analyzing infection rates before and after the Food and Drug Administration ban on bacitracin irrigation. METHODS: A single-institution retrospective chart review was conducted. Eligible patients underwent implant-based breast reconstruction after mastectomy from October 1, 2016, to July 31, 2022. Procedure date, reconstruction type, patient comorbidities, use of bacitracin irrigation, postoperative infection, and secondary outcomes were collected. Univariate and multivariable logistic regression analyses were performed. RESULTS: A total of 188 female patients were included in the study. Bacitracin use did not protect against infection in univariate or multivariable analysis. Age greater than 50 years was associated with an increased risk of postoperative infection ( P = 0.0366). The presence of comorbidities, smoker status, neoadjuvant therapy treatment before surgery, implant placement, and laterality were all not significantly associated with postoperative infection development. CONCLUSIONS: The results of this study demonstrate a lack of association between bacitracin use and postoperative infection. Additional research into the optimal antibiotic for perioperative irrigation is needed, as bacitracin is not encouraged for use.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Roy N, Oleru O, Amakiri U, et al. Outcomes After Implant-Based Breast Reconstruction Following the National Institution of a Ban on Bacitracin Irrigation. Ann Plast Surg. 2024. PMID: 38319958. doi:10.1097/SAP.0000000000003794

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。